20/07/2007 01:00:00
UK: GW pulls cannabis drug in Europe, to resubmit 2008
---
LONDON, July 20 (Reuters) - Britain's GW Pharmaceuticals Plc (GWP.L:
Quote, Profile, Research) said on Friday it was withdrawing its
application for European approval of its pioneering cannabis-based drug
and would resubmit it to regulators with extra data in 2008.
"We recognise that it is taking longer than we had hoped for Sativex to
obtain approval in Europe," GW Chairman Geoffrey Guy said in a
statement. "Each step, however, has been one of progress towards
achieving this goal."
http://www.reuters.com/article/health-SP/idUSWLB912920070720
Source:
http://www.ukcia.org/news/shownewsarticle.php?articleid=12722
Author:
Reuters via UKCIA
|